234 related articles for article (PubMed ID: 22282373)
21. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
22. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).
Ando N; Kato H; Igaki H; Shinoda M; Ozawa S; Shimizu H; Nakamura T; Yabusaki H; Aoyama N; Kurita A; Ikeda K; Kanda T; Tsujinaka T; Nakamura K; Fukuda H
Ann Surg Oncol; 2012 Jan; 19(1):68-74. PubMed ID: 21879261
[TBL] [Abstract][Full Text] [Related]
24. Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.
Yonemura M; Katsumata N; Hashimoto H; Satake S; Kaneko M; Kobayashi Y; Takashima A; Kato Y; Takeuchi M; Fujiwara Y; Yamamoto H; Hojo T
Jpn J Clin Oncol; 2009 Jul; 39(7):443-8. PubMed ID: 19395466
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer.
Shimakawa T; Naritaka Y; Asaka S; Isohata N; Murayama M; Konno S; Yoshimatsu K; Shiozawa S; Katsube T; Ogawa K
Anticancer Res; 2008; 28(4C):2321-6. PubMed ID: 18751413
[TBL] [Abstract][Full Text] [Related]
26. Intensified neoadjuvant chemoradiotherapy in locally advanced rectal cancer -- impact on long-term quality of life.
Kripp M; Wieneke J; Kienle P; Welzel G; Brade J; Horisberger K; Wenz F; Post S; Gencer D; Hofmann WK; Hofheinz RD
Eur J Surg Oncol; 2012 Jun; 38(6):472-7. PubMed ID: 22349986
[TBL] [Abstract][Full Text] [Related]
27. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
28. [Effects of intravenous and oral administration of ondansetron hydrochloride on chemotherapy-induced nausea and vomiting in patients with esophageal cancer].
Miyashita M; Onda M; Ikeda K; Bando K; Hagiwara N; Tsuchiya Y; Yoshiyuki T; Kiyama T; Saito T; Sasajima K; Yamashita K
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1629-35. PubMed ID: 10553422
[TBL] [Abstract][Full Text] [Related]
29. Improved food intake and reduced nausea and vomiting in patients given a restricted diet while receiving cisplatin chemotherapy.
Menashian L; Flam M; Douglas-Paxton D; Raymond J
J Am Diet Assoc; 1992 Jan; 92(1):58-61. PubMed ID: 1728624
[TBL] [Abstract][Full Text] [Related]
30. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
Warr DG; Grunberg SM; Gralla RJ; Hesketh PJ; Roila F; Wit Rd; Carides AD; Taylor A; Evans JK; Horgan KJ
Eur J Cancer; 2005 Jun; 41(9):1278-85. PubMed ID: 15939263
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of quality of life of patients with oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study-first results].
Wiltfang J; Grabenbauer G; Bloch-Birkholz A; Leher A; Neukam FW; Kessler P
Strahlenther Onkol; 2003 Oct; 179(10):682-9. PubMed ID: 14566476
[TBL] [Abstract][Full Text] [Related]
32. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
Gibson MK; Li Y; Murphy B; Hussain MH; DeConti RC; Ensley J; Forastiere AA;
J Clin Oncol; 2005 May; 23(15):3562-7. PubMed ID: 15908667
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
34. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy.
Ravasco P; Monteiro-Grillo I; Marques Vidal P; Camilo ME
Head Neck; 2005 Aug; 27(8):659-68. PubMed ID: 15920748
[TBL] [Abstract][Full Text] [Related]
35. Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02).
Ohnishi S; Watari H; Kanno M; Ohba Y; Takeuchi S; Miyaji T; Oyamada S; Nomura E; Kato H; Sugiyama T; Asaka M; Sakuragi N; Yamaguchi T; Uezono Y; Iwase S
J Gynecol Oncol; 2017 Sep; 28(5):e44. PubMed ID: 28657216
[TBL] [Abstract][Full Text] [Related]
36. Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial.
Ringash J; Au HJ; Siu LL; Shapiro JD; Jonker DJ; Zalcberg JR; Moore MJ; Strickland A; Kotb R; Jeffery M; Alcindor T; Ng S; Salim M; Sabesan S; Easaw JC; Shannon J; El-Tahche F; Walters I; Tu D; O'Callaghan CJ; ;
Cancer; 2014 Jan; 120(2):181-9. PubMed ID: 24127364
[TBL] [Abstract][Full Text] [Related]
37. [Autologous cytokine-induced killer cells therapy on the quality of life of patients with breast cancer after adjuvant chemotherapy: a prospective study].
Liang XF; Ma DC; Ding ZY; Liu ZZ; Guo F; Liu L; Yu HY; Han YL; Xie XD
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):764-8. PubMed ID: 24378099
[TBL] [Abstract][Full Text] [Related]
38. Plasma ghrelin levels as a predictor of adverse renal events due to cisplatin-based chemotherapy in patients with esophageal cancer.
Yanagimoto Y; Takiguchi S; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Mori M; Doki Y
Jpn J Clin Oncol; 2016 May; 46(5):421-6. PubMed ID: 26839323
[TBL] [Abstract][Full Text] [Related]
39. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial.
Neary NM; Small CJ; Wren AM; Lee JL; Druce MR; Palmieri C; Frost GS; Ghatei MA; Coombes RC; Bloom SR
J Clin Endocrinol Metab; 2004 Jun; 89(6):2832-6. PubMed ID: 15181065
[TBL] [Abstract][Full Text] [Related]
40. Effect of transcutaneous electrical acupoint stimulation combined with palonosetron on chemotherapy-induced nausea and vomiting: a single-blind, randomized, controlled trial.
Xie J; Chen LH; Ning ZY; Zhang CY; Chen H; Chen Z; Meng ZQ; Zhu XY
Chin J Cancer; 2017 Jan; 36(1):6. PubMed ID: 28069044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
